KATIE LINDSAY: Open Payments
NPI 1629551353 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 67 payments from 9 companies in 2025. Trend: 2023 $270 · 2024 $641 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $244 |
| Janssen Biotech, Inc. | 12 | $217 |
| Madrigal Pharmaceuticals | 13 | $161 |
| Lilly USA, LLC | 8 | $146 |
| GENZYME CORPORATION | 4 | $85 |
| QOL Medical, LLC | 2 | $63 |
| Phathom Pharmaceuticals, Inc. | 9 | $57 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Ardelyx, Inc. | 1 | $19 |
Products named: TREMFYA, REZDIFFRA, OMVOH, RINVOQ, DUPIXENT, MAVYRET, Sucraid, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
